-
-
Representatives of leading health care and consumer groups have endorsed 30 patient safety practices they say should be universally used in health care settings to reduce the risk of harm resulting from processes, systems, or environments of care.
-
Increasingly, hospitals and other health care facilities are finding that they cant seriously reduce back injuries without using machines to do the lifting.
-
After an initial round of laser surgery on her face, the patient consented to a second procedure, which was limited to an eyelid tuck and minor laser surgery to her chin. Despite the limitation, the ophthalmologist performed a full-face laser procedure, inadvertently resulting in second- and third-degree burns.
-
PARIS Conference leaders initiated a new feature at the 14th European Paris Course on Revascularization (EuroPCR), held here in late May. Ten emerging companies were selected from among many contenders based on the innovative nature of their cardiovascular technologies and the clinical solutions they provide.
-
Abbott Laboratories (Abbott Park, Illinois) entered into an asset purchase agreement for the coronary and peripheral interventional business line of the Jomed Group, a provider of minimally invasive vascular interventional devices, for EUR 60 million.
-
Boston Scientific (Natick, Massachusetts) reported June 20 that the U.S. Court of Appeals for the Seventh Circuit had substantially affirmed a U.S. District Court decision in favor of the company in its dispute with Cook (Bloomington, Indiana) over Cooks agreements with Guidant (Indianapolis, Indiana) relating to paclitaxel-coated stents.
-
A decision made last month by the Centers for Medicare & Medicaid Services (CMS; Baltimore, Maryland) means another 90,000 patients a year will qualify for reimbursement coverage to receive implantable cardioverter defibrillators (ICDs), but the coverage guidelines fall short for another 200,000 people researchers say would benefit from the devices.
-
Timothy Moore, MD, has been named chief medical officer and executive vice president for Alere Medical (Reno, Nevada). Moore most recently was chief medical officer and senior vice president of Health Net.
-
A second company earned U.S. regulatory approval in the embolic protection field last month, with Boston Scientifics (Natick, Massachusetts) FilterWire EX Embolic Protection System joining Medtronics (Minneapolis, Minnesota) PercuSurge GuardWire Plus system, which was approved by the FDA in June 2001.
